Cargando…

Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study

INTRODUCTION: Colon cancer impacts the lives of Kansans and those across the United States. Epidermal growth factor receptor (EGFR) inhibitors, such as panitumumab and cetuximab, have gained popularity as first-line treatment for stage 4 colon cancer despite their toxicities and have been used by cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Braden M., Pham, Tony A., Young, Kate J., Bantis, Leonidas E., Sun, Weijing, Kasi, Anup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Kansas Medical Center 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409940/ https://www.ncbi.nlm.nih.gov/pubmed/36042840 http://dx.doi.org/10.17161/kjm.vol15.15975

Ejemplares similares

Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma
por: McGinnis, Timothy, et al.
Publicado: (2020)

Microsatellite Instability with BRAF V600E Associated with Delayed Presentation but Poor Survival in Stage III Colorectal Cancer
por: Karki, Sophiya, et al.
Publicado: (2023)

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
por: Kasi, Anup, et al.
Publicado: (2020)

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2020)

Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey
por: Kasi, Anup, et al.
Publicado: (2021)

Is obesity a risk factor in cancer patients with COVID-19?
por: Park, Robin, et al.
Publicado: (2021)

Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease
por: Gopinath, Chaitra, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
por: Saeed, Anwaar, et al.
Publicado: (2020)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
por: Park, Robin, et al.
Publicado: (2020)

Are All Mutations the Same? A Rare Case Report of Coexisting Mutually Exclusive KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma
por: Vittal, Anusha, et al.
Publicado: (2017)

A Curious Case of Colonic Perivascular Epithelioid Cell Tumor: A Unique Diagnosis With Variable Presentations
por: Bennett, Joseph, et al.
Publicado: (2020)

How does lymph node yield affect survival outcomes of stage I and II colon cancer?
por: Foo, Chi Chung, et al.
Publicado: (2020)

Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Kasi, Anup, et al.
Publicado: (2020)

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma
por: Saji, Hisashi, et al.
Publicado: (2017)

Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
por: Chen, Chen (Amy), et al.
Publicado: (2015)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)

Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy
por: Kasi, Anup, et al.
Publicado: (2021)

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chidharla, Anusha, et al.
Publicado: (2023)

PSAT380 Characteristics and prognosis of Differentiated Thyroid Cancer in patients with Graves Disease
por: Panthi, Sujata, et al.
Publicado: (2022)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Colon Cancer Sidedness, Presentation, and Survival at Different Stages
por: Ulanja, Mark B., et al.
Publicado: (2019)

Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
por: Hachisuka, Junichi, et al.
Publicado: (2011)

Does surgical margin affect recurrence and survival after sublobar pulmonary resection for lung cancer?
por: Liu, Weijing, et al.
Publicado: (2021)

Does ocular treatment of uveal melanoma influence survival?
por: Damato, B
Publicado: (2010)

Multidisciplinary Treatment in Toxic Epidermal Necrolysis
por: Surowiecka, Agnieszka, et al.
Publicado: (2023)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
por: Allen, Jessica, et al.
Publicado: (2020)

Transmigration or Epidermization of Lip: Does an Entity Exist?
por: Neema, Shekhar, et al.
Publicado: (2020)

Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014
por: Junior, Gilberto de Lima Lopes
Publicado: (2014)

Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer
por: Ketzer, Sander, et al.
Publicado: (2017)

Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study
por: Ye, Jing-Ren, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor Expression in Esophageal Adenocarcinoma: Relationship with Tumor Stage and Survival after Esophagectomy
por: Navarini, Daniel, et al.
Publicado: (2012)

Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study
por: Lan, Yan, et al.
Publicado: (2021)

Challenges and solutions in patient treatment strategies for stage II colon cancer
por: Fotheringham, Susan, et al.
Publicado: (2019)

Important updates from the AACR virtual meeting: COVID-19 and cancer
por: Ripp, Jacob, et al.
Publicado: (2020)

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2023)

Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer
por: Li, Hongbo, et al.
Publicado: (2020)

Prediction of Colon Cancer Stages and Survival Period with Machine Learning Approach
por: Gupta, Pushpanjali, et al.
Publicado: (2019)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
por: Freed, Ian M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8kepapv8fr6hcp153ed6co1qp